gnln.com
Home Tags FDA

Tag: FDA

Legislators Introduce Bill to Allow CBD in Dietary Supplements-CBD news-CBDToday

Legislators Introduce Bill to Allow CBD in Dietary Supplements

WASHINGTON, D.C. – House Representatives Kurt Schrader (D-Ore.) and Morgan Griffith (R-Va.) on September 4 introduced the Hemp and Hemp-Derived CBD Consumer Protection and...
FDA-CBD Product Testing-CBDToday

FDA Planning for Large-Scale CBD Product Testing

WASHINGTON, D.C. – The Food and Drug Administration (FDA) recently published a "contract opportunity" advertisement to the Federal government's beta website for "people who...
FDA Approves More Uses for Epidiolex-CBD News-CBDToday

FDA Approves More Uses for Epidiolex

CARLSBAD, Calif. – Epidiolex, the first FDA-approved prescription medication containing a cannabis derivative, has received approval from the U.S. Food and Drug Administration for...
CBD products-FDA Approval-Anita Sabine-Alexa Singh-Manatt Phelps Phillips-CBDToday

Is CBD on the Cusp of FDA Approval?

Don’t believe everything you read. Despite the widespread misinformation campaign that cannabidiol (CBD), which is believed to provide medical benefits, is fully legal, that...
FDA draft guidance-Cannabis-Derived Compounds-hemp research-CBD-CBDToday

FDA Releases Guidelines on Research Related to Cannabis-Derived Compounds

WASHINGTON, D.C. – The Food and Drug Administration (FDA) this week released draft guidelines for the creation of cannabis research regulations. The guidance titled...
Department of Transportation-drug testing Commercial Drivers-CBD-CBDToday

DOT Cautions Commercial Drivers: CBD Products May Lead to Positive Drug Tests

WASHINGTON, D.C. – As the hemp industry matures, cannabidiol products such as oils and massage creams continue to gain mainstream success specifically because they...
Summit Labs CBD Oil Recall-FDA-CBD news-CBDToday

Product Recall Issued for CBD Oil Due to Lead Contamination

WASHINGTON, D.C. – A batch of CBD oil has been voluntarily recalled by its manufacturer after testing positive for higher than acceptable levels of...
epidiolex_legal_CBDToday

Key DEA Change Could Make Cannabinoid-Based Medicine More Accessible 

Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.
New Frontier Data-webinar-coronavirus-CBD-CBDToday

New Frontier Webinar Focuses on Risk, Opportunity Amid Coronavirus Crisis

Marketing data firm New Frontier Data yesterday hosted a day-long webinar on the effect of the coronavirus (COVID-19) crisis on the global cannabis and...
FDA public comment period on CBD-CBDToday

FDA Continues Public Comment Period on CBD ‘Indefinitely’

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) on Wednesday published a report in response to the U.S. Congress’ request for guidelines...
Advertisement
KushyCBD

TOP STORIES